Discontinuation of metformin in the setting of coronary angiography: Clinical uncertainty amongst physicians reflecting a poor evidence base

EuroIntervention

Volumn 7, Issue 9, 2012, Pages 1103-1110

  Maznyczka, Annette ^a   Myat, Aung ^b   Gershlick, Anthony ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Coronary angiography; Guidelines; Lactic acidosis; Metformin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN; METFORMIN; SULFONYLUREA;

ANGIOCARDIOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HEALTH CARE MANAGEMENT; HUMAN; LACTIC ACIDOSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; PRACTICE GUIDELINE; REVIEW; SYSTEMATIC REVIEW; UNITED KINGDOM;

ACIDOSIS, LACTIC; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; DATA COLLECTION; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; WITHHOLDING TREATMENT;

EID: 84856266622     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I9A175     Document Type: Review

References (34)

1. Webb JAW. Non-insulin-dependent diabetes and contrast media, in Thomsen HS, Webb JAW. Contrast media: safety issues and ESUR Guidelines. 2nd edition. Springer 2008.
2. Holstein A, Stumvoll M. Contraindications can damage your health - is metformin a case in point? Diabetologica 2005;48: 2454-2459. (Pubitemid 41738207)
3. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996;81:4059-4067. (Pubitemid 26380418)
4. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med. 2002;137:25-33. (Pubitemid 34705373)
5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865.
6. Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 1995;49:721-749.
7. Khurana R, Malik IS. Metformin: safety in cardiac patients. Postgrad Med J 2010;86:371-373.
8. Dembo AJ, Marliss EB, Halperin ML. Insulin therapy in phenformin-associated lactic acidosis; a case report, biochemical considerations and review of the literature. Diabetes 1975;24: 28-35.
9. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303. (Pubitemid 29383658)
10. Cavallo-Perin P, Aluffi E, Estivi P, Bruno A, Carta Q, Pagano G, Lenti G. The hyperlactataemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment. Eur Rev Med Pharmacol Sci 1989;11:45-49. (Pubitemid 19096050)
11. Bailey CJ, Turner RC. Metformin. New Engl J Med 1996;334:574-579. (Pubitemid 126537875)
12. Sulkin TV, Bosman D, Krentz AJ. Contraindications to metformin therapy in patients with NIDDM. Diabetes Care 1997;20: 925-928. (Pubitemid 27224940)
13. Lalau JD, Race JM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999;20:377-384.
14. Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van't Hof AW. Hyperglycaemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005;45:1999-1002.
15. Goergen SK, Rumbold G, Compton G, Harris C. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. Radiology 2010;254:261-269.
16. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010. (4):CD002967.
17. Stang MR, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999;22:925-927. (Pubitemid 29241046)
18. Parra D, Legreid AM, Beckey NP, Reyes S. Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media. Pharmacotherapy 2004;24:987-993. (Pubitemid 39025198)
19. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-1399. (Pubitemid 39303939)
20. Stades AM, Heikens JT, Erkelens DW, Holleman F, Hoekstra JB. Metformin and lactic acidosis: cause or coincidence? A review of case reports. J intern Med 2004;255:179-187. (Pubitemid 38241362)
21. McCartney MM, Gilbert FJ, Murchison LE, Pearson D, McHardy K, Murray AD. Metformin and contrast media - a dangerous combination? Clin Radiol. 1999;54:29-33. (Pubitemid 29020889)
22. Nawaz S, Cleveland T, Gaines PA, Chan P. Clinical risk associated with contrast angiography in metformin treated patients: a clinical review. Clin Radiol 1998;53:342-344. (Pubitemid 28230866)
23. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA. Lactic acidosis in patients with diabetes treated with metformin. N Eng J Med 1998;338:265-266. (Pubitemid 28047587)
24. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia a nested case-control analysis. Diabetes Care 2008;31:2086-2091.
25. Cryer DR, Nicholas SP, Henry DH, Miles DJ, Stadel BV. Comparative outcomes study of metformin intervention versus conventional approach the COSMIC approach study. Diabetes Care 2005;28:539-543. (Pubitemid 40315310)
26. Boyle JG, McKay GA, Fisher M. Drugs for diabetes: part 1 metformin. Br J Cardiol 2010;17:231-234.
27. Wijns W, Kolh P, Danchin N, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Uva MS, Taggart D. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010;31: 2501-2555.
28. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegl B; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).American Heart Association Web Site. Available at: http://www.americanheart.org. Circulation 2006;113:e166-286.
29. The Royal Australian and New Zealand College of Radiologists. RANZCR Guidelines for iodinated contrast administration. March 2009. Available from: http://www.ranzcr.edu.au/. Accessed on: 27th February 2010.
30. Board of the faculty of clinical radiology. The Royal College of Radiologists (2005). Standards for iodinated intravascular contrast agent administration to adult patients. Royal College of Radiologists, London.
31. The Royal College of Radiologists. Metformin updated guidance for use in diabetics with renal impairment. London: The Royal College of Radiologists, 2009.
32. European Society of Urogenital Radiology (ESUR) guidelines on contrast media version 7.0. ESUR contrast media safety committee. August 2008. Available from: www.esur.org. Accessed on: 20th September 2009.
33. National institute for health and clinical excellence. Quick reference guide - the management of type 2 diabetes. 2009. Available from: http://www.nice.org.uk/nicemedia/pdf/CG87QuickRefGuide.pdf. Accessed on: 27th February 2010.
34. Aguilar C, Reza A, García JE, Rull JA. Biguanide related lactic acidosis: incidence and risk factors. Arch Med Res 1992;23:19-24. (Pubitemid 23055872)